Necrotizing Ulcerative Gingivitis Treatment Market Size

  • Report ID: 3596
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Necrotizing Ulcerative Gingivitis Treatment Market Size

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market size was valued at USD 1.01 Billion in 2023 and is expected to exceed USD 4.42 Billion by the end of 2036, expanding at over 12.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of necrotizing ulcerative gingivitis treatment is evaluated at USD 1.12 Billion. The growth of the market can be attributed to the rising number of people suffering from HIV or AIDs across the world. The presence of HIV or AIDs increases the risk of oral issues as HIV suppresses the immune system of the body making it weak to fight against any smaller disease or infection. HIV-associated gingivitis is called linear gingival erythema and is caused by herpes simplex virus type 1 (HSV-1). As per the statistical report of the World Health Organization, 38.4 million population around the globe was suffering from HIV by the end of 2021, and about 650,000 people died from HIV and other related illnesses in the same year.

Also, the poor oral habits of people across the world especially in rural areas owing to lack of knowledge is estimated to propel the market growth in the coming years. Oral hygiene is most important to avoid or prevent any kind of teeth, gum, and oral infections and diseases. The increasing number of people suffering from the formation of plaque around the teeth as well as swollen gums is estimated to drive the market growth during the forecast period. Regular brushing and flossing of teeth are very important for oral health and remove the presence of bacteria or fungi deposits. As per the reports of 2019, more than 30% of the American population failed to brush their teeth two times a day, and over 1.6 % of people admitted that they do not brush at least once a day.


Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3596
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing ulcerative gingivitis treatment is evaluated at USD 1.12 Billion.

The necrotizing ulcerative gingivitis treatment market size was valued at USD 1.01 Billion in 2023 and is expected to exceed USD 4.42 Billion by the end of 2036, expanding at over 12.1% CAGR during the forecast period i.e., between 2024-2036. Growing incidences of oral diseases, and poor diet and dental hygiene are the major factors driving the market growth.

North America is likely to be the largest with a share of about 32% by 2036, attributed to increasing prevalence of oral diseases in developed countries, including the US, driven by poor diet, and high cases of diabetes amongst the people.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample